
    
      A Randomized, Double-Blind, Parallel-Group, 24-Week, Chronic-Dosing, Multi-Center Study to
      Assess the Efficacy and Safety of PT010, PT003, and PT009 Compared With Symbicort®
      Turbuhaler® as an Active Control in Subjects with Moderate to Very Severe Chronic Obstructive
      Pulmonary Disease

      This study includes the following 3 sub-studies: 12-hour Pulmonary Function Test (PFT),
      Pharmacokinetic (PK) Profile, and Hypothalamic-pituitary-adrenal Axis.
    
  